Homechoice Claria combines a simple user interface with the benefits of Sharesource, the only two-way remote patient management platform for patients on peritoneal dialysis in the
'Our goal remains to expand accessibility to home-based therapy for
Enabling Enhanced Care with Remote Patient Management
With one in four APD patients globally benefitting from Baxter's two-way remote patient management technology, Sharesource offers patients and clinicians the ability to stay closely connected to proactively address key aspects of peritoneal dialysis (PD) therapy. Through the platform's accurate, daily treatment data and analytics, clinicians can manage patients remotely and make timely therapy decisions while keeping patients safely at home. Clinicians using Homechoice Claria with Sharesource also have greater visibility to patient adherence patterns, which may allow for early intervention and an increased focus on proactive care.2 To date, more than 6 million home dialysis treatments completed in the
Homechoice Claria offers enhanced features that facilitate added convenience for patients and clinical teams, as well as best-in-class educational companions to further simplify the PD experience. For patients, intuitive control buttons and an easy-to-read screen complement straightforward instructions in 38 languages. To extend patients' learning beyond the clinic, MyClaria a web-based app included as part of the Homechoice Claria system features step-by-step, voice activated and enabled instructions to guide patients through therapy. For clinicians, MySharesource also a web-based app is a resource featuring step-by-step guidance and quick demo videos on how to use the Sharesource platform.
'When starting their patients on PD, clinicians are looking for ways to help manage their changing needs over time,' said
Adding Homechoice Claria to its APD cycler portfolio enhances Baxter's efforts to bring the benefits of Sharesource remote patient management to as many clinics and patients as possible in the
Developing the
About Baxter
Every day, millions of patients and caregivers rely on Baxter's leading portfolio of critical care, nutrition, renal, hospital and surgical products. For more than 85 years, we've been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, technologies and therapies available in more than 100 countries, Baxter's employees worldwide are now building upon the company's rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
The Homechoice Claria APD system is intended for automatic control of dialysis solution exchanges in the treatment of pediatric and adult renal failure patients undergoing peritoneal dialysis in the home healthcare environment, including comparable use in professional healthcare facilities.
This release includes forward-looking statements concerning Homechoice Claria and Sharesource, including anticipated availability and potential benefits associated with their use. The statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those in the forward-looking statements: satisfaction of regulatory and other requirements; actions of regulatory bodies and other governmental authorities; product quality, manufacturing or supply, or patient safety issues; changes in law and regulations and other risks identified in Baxter's most recent filing on Form 10-K and other
Contact:
Tel: 1-224-948-3020
Email: investor.baxter.com
(C) 2020 Electronic News Publishing, source